John M. Leonard, President and CEO at Intellia Therapeutics, Inc. (NTLA), sold 45,364 shares at $150.46 ($6.9M) on 2021-08-19, disclosed to the SEC on 2021-08-20.
Open-market sale of $6.9M NTLA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.46 | 9,726 | $1.5M | 21.3% |
| 2 | $150.46 | 9,726 | $1.5M | 21.3% |
| 3 | $151.56 | 6,993 | $1.1M | 15.4% |
| 4 | $151.56 | 6,993 | $1.1M | 15.4% |
| 5 | $152.30 | 5,963 | $908K | 13.2% |
| 6 | $152.30 | 5,963 |
| $908K |
| 13.2% |
| Total | $151.28 avg | 45,364 | $6.9M | 100% |
| Filing → |
| NTLA | SELL | 2025-12-12 | $1.7M | — | Filing → |
| NTLA | SELL | 2025-01-07 | $653K | — | Filing → |
| NTLA | SELL | 2024-01-05 | $1.1M | — | Filing → |